208 related articles for article (PubMed ID: 23139598)
21. Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis.
Kondo K; Shinoda T; Yoshimoto H; Takazoe M; Hamada T
Ther Apher; 2001 Dec; 5(6):462-5. PubMed ID: 11800081
[TBL] [Abstract][Full Text] [Related]
22. Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis.
Mitsuyama K; Andoh A; Masuda J; Yamasaki H; Kuwaki K; Takedatsu H; Seki R; Nishida H; Tsuruta O; Sata M
Ther Apher Dial; 2008 Aug; 12(4):271-7. PubMed ID: 18789113
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
Yajima T; Takaishi H; Kanai T; Iwao Y; Watanabe M; Ishii H; Hibi T
Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
[TBL] [Abstract][Full Text] [Related]
24. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo Y; Matsumoto T; Mibu R; Iida M
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
[TBL] [Abstract][Full Text] [Related]
25. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
Fukuchi T; Nakase H; Matsuura M; Yoshino T; Toyonaga T; Ohmori K; Ubukata S; Ueda A; Eguchi T; Yamashita H; Ito D; Ashida K
J Crohns Colitis; 2013 Nov; 7(10):803-11. PubMed ID: 23352104
[TBL] [Abstract][Full Text] [Related]
26. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.
Okada H; Makidono C; Takenaka R; Hiraoka S; Fujiwara A; Kato J; Kawahara Y; Kawamoto H; Mizuno M; Shiratori Y
Digestion; 2006; 74(1):15-8. PubMed ID: 16940730
[TBL] [Abstract][Full Text] [Related]
28. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
[TBL] [Abstract][Full Text] [Related]
30. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
Ashida T; Kohgo Y; Munakata A; Noguchi M; Iizuka B; Endo Y; Hanai H; Yoshikawa T; Matsumoto T; Aoyama N; Matsui T; Mitsuyama K; Hibi T
Transfus Apher Sci; 2011 Apr; 44(2):113-7. PubMed ID: 21402309
[TBL] [Abstract][Full Text] [Related]
31. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
Krznarić Ž; Markoš P; Golubić Ćepulić B; Čuković-Čavka S; Domislović V; Bojanić I; Barišić A; Kekez D
Acta Clin Croat; 2019 Sep; 58(3):529-534. PubMed ID: 31969767
[TBL] [Abstract][Full Text] [Related]
32. A current overview of corticosteroid use in active ulcerative colitis.
Salice M; Rizzello F; Calabrese C; Calandrini L; Gionchetti P
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):557-561. PubMed ID: 30947569
[TBL] [Abstract][Full Text] [Related]
33. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain.
de Carpi JM
Drugs Context; 2022; 11():. PubMed ID: 35371271
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
Naganuma M; Yokoyama Y; Motoya S; Watanabe K; Sawada K; Hirai F; Yamamoto T; Hanai H; Omori T; Kanai T; Hibi T;
J Gastroenterol; 2020 Apr; 55(4):390-400. PubMed ID: 31811562
[TBL] [Abstract][Full Text] [Related]
36. Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis.
Yamasaki S; Sakata Y; Yoshida H; Shirai S; Tanaka Y; Nakano R; Yukimoto T; Tsuruoka N; Shimoda R; Fukuda M; Miyazono M; Ikeda Y; Iwakiri R; Anzai K; Fujimoto K
Digestion; 2019; 100(4):247-253. PubMed ID: 30540999
[TBL] [Abstract][Full Text] [Related]
37. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Yamamoto T; Umegae S; Matsumoto K
J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
[TBL] [Abstract][Full Text] [Related]
38. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
Iida T; Ikeya K; Kato M; Abe J; Yamamoto M; Watanabe F; Sugimoto K; Hanai H
Digestion; 2017; 96(2):119-126. PubMed ID: 28796990
[TBL] [Abstract][Full Text] [Related]
39. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?
Panés J; Guilera M; Ginard D; Hinojosa J; González-Carro P; González-Lara V; Varea V; Domènech E; Badia X
Dig Liver Dis; 2007 Jul; 39(7):617-25. PubMed ID: 17531555
[TBL] [Abstract][Full Text] [Related]
40. Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.
Nakase H; Mikami S; Matsuura M; Ueno S; Uza N; Inoue S; Kitamura H; Kasahara K; Yoshino T; Takeda Y; Chiba T
Intern Med; 2007; 46(11):717-20. PubMed ID: 17541222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
